# Mycophenolate mofetil

## Cellcept 250mg

##### 臨採

| Title              | Content                                                                                                                                                                                                                                                |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| TAH Drug Code      | OCELL                                                                                                                                                                                                                                                  |
| Indications        | Prophylaxis of acute organ rejection in patients receiving allogeneic renal， cardiac & hepatic transplants， concomitantly w/ cyclosporin & corticosteroids. Induction & maintenance treatment of lupus nephritis， concomitantly w/ corticosteroids. |
| Dosing             | Renal transplant 1 g BID. Cardiac & hepatic transplant 1.5 g BID. Lupus nephritis induction dose 0.75-1.5 g BID， maintenance dose 0.25-1 g BID.                                                                                                       |
| Hepatic Impairment | Dose adjustment required                                                                                                                                                                                                                               |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                               |
| Contraindications  | Hypersensitivity to mycophenolate mofetil or mycophenolic acid (MPA).                                                                                                                                                                                  |
| Adverse Effects    | Diarrhoea， dyspepsia， vomiting， elevated liver function test， acne， leucopenia， sepsis， certain infections; CV， metabolic， CNS & musculoskeletal events.                                                                                      |
| Pregnancy          | Human (and animal) data suggest risk                                                                                                                                                                                                                   |
| Lactation          | Contraindicated                                                                                                                                                                                                                                        |

